Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04628767
Title Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors National Cancer Institute (NCI)

renal pelvis transitional cell carcinoma

ureter transitional cell carcinoma


Durvalumab + Gemcitabine

Cisplatin + Doxorubicin + Methotrexate + Pegfilgrastim + Vinblastine

Cisplatin + Doxorubicin + Durvalumab + Methotrexate + Pegfilgrastim + Vinblastine

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.